Nagawa Catherine S, Rigotti Nancy A, Chang Yuchiao, Levy Douglas E, Streck Joanna M, Ylioja Thomas, Lee Scott S, Tindle Hilary A
From the Tobacco Research and Treatment Center, Department of Medicine, Massachusetts General Hospital, Boston, MA (CSN, NAR, YC, DEL, JMS); Harvard Medical School, Boston, MA (NAR, YC, DEL, JMS); Harvard T.H. Chan School of Public Health, Boston, MA (CSN); National Jewish Health, Denver, CO (TY); Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (SL, HAT); and Geriatric Research Education and Clinical Centers, Veterans Affairs Tennessee Valley Healthcare System, Nashville, TN (HAT).
J Addict Med. 2025;19(1):4-11. doi: 10.1097/ADM.0000000000001358. Epub 2024 Aug 8.
Some people who stop smoking experience improved mood, but few studies have examined this relationship after hospitalization or accounted for concomitant substance use and psychological factors. We examined associations between smoking abstinence after a hospital discharge and change in depression and anxiety symptoms.
We conducted a secondary analysis of data from the Helping HAND 4 smoking cessation trial, which enrolled people who used tobacco when admitted to three academic medical center general hospitals. Participants (n = 986) were categorized as continuously abstinent (CA) or not. We used linear and logistic regression to model continuous and binary measures of depression (Patient Health Questionnaire [PHQ-8] ≥/<10), and anxiety (Generalized Anxiety Disorder Assessment [GAD-7], ≥/<8) over 6 months, adjusting for baseline mood, psychological factors, and substance use. Binary outcomes were defined using established clinical thresholds to aid in the clinical interpretation of the results.
Mean age was 52.3 years, 56.5% were female, and the baseline mean cigarettes/day was 16.2 (SD: 3.2). In the adjusted analyses, depression and anxiety scores improved more in CA than non-CA participants over 6 months (difference-in-improvement, 2.43 [95% CI: 1.50-3.36] for PHQ-8; 3.04 [95% CI: 2.16-3.93] for GAD-7). At 6 months, CA participants were more likely to have a PHQ-8 score <10 (aOR = 2.07 [95% CI: 1.36-3.16]) and a GAD-7 score <8 (aOR = 2.90 [95% CI: 1.91-4.39]).
Individuals who were CA, compared to those who were not, had fewer depression and anxiety symptoms at 6 months, and were twice as likely to score below the population screening thresholds for major depression and anxiety disorders. Clinicians should emphasize the association between continuous abstinence and improved mood symptoms after hospital discharge.
一些戒烟的人情绪有所改善,但很少有研究在住院后考察这种关系,或考虑到同时存在的物质使用和心理因素。我们研究了出院后戒烟与抑郁和焦虑症状变化之间的关联。
我们对“帮助戒烟”4戒烟试验的数据进行了二次分析,该试验纳入了入住三家学术医疗中心综合医院时使用烟草的人。参与者(n = 986)被分类为持续戒烟(CA)或未戒烟。我们使用线性和逻辑回归对6个月内抑郁(患者健康问卷[PHQ-8]≥/<10)和焦虑(广泛性焦虑症评估[GAD-7],≥/<8)的连续和二元测量进行建模,调整基线情绪、心理因素和物质使用情况。二元结局使用既定的临床阈值定义,以帮助对结果进行临床解释。
平均年龄为52.3岁,56.5%为女性,基线时平均每日吸烟量为16.2支(标准差:3.2)。在调整分析中,6个月内CA参与者的抑郁和焦虑得分比非CA参与者改善得更多(PHQ-8改善差异为2.43[95%置信区间:1.50 - 3.36];GAD-7为3.04[95%置信区间:2.16 - 3.93])。在6个月时,CA参与者更有可能PHQ-8得分<10(校正比值比[aOR]=2.07[95%置信区间:1.36 - 3.16])和GAD-7得分<8(aOR = 2.90[95%置信区间:1.91 - 4.39])。
与未持续戒烟的人相比,持续戒烟的人在6个月时抑郁和焦虑症状更少,且得分低于重度抑郁和焦虑症人群筛查阈值的可能性是其两倍。临床医生应强调持续戒烟与出院后情绪症状改善之间的关联。